Hantz Financial Services’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20K | Buy |
727
+630
| +649% | +$17.3K | ﹤0.01% | 1276 |
|
|
2025
Q1 | $3K | Sell |
97
-13
| -12% | -$402 | ﹤0.01% | 1301 |
|
|
2024
Q4 | $5K | Sell |
110
-45
| -29% | -$2.05K | ﹤0.01% | 893 |
|
|
2024
Q3 | $10K | Buy |
155
+2
| +1% | +$129 | ﹤0.01% | 791 |
|
|
2024
Q2 | $18K | Sell |
153
-118
| -44% | -$13.9K | ﹤0.01% | 738 |
|
|
2024
Q1 | $29K | Sell |
271
-170
| -39% | -$18.2K | ﹤0.01% | 711 |
|
|
2023
Q4 | $44K | Buy |
441
+2
| +0.5% | +$200 | ﹤0.01% | 662 |
|
|
2023
Q3 | $45K | Buy |
439
+19
| +5% | +$1.95K | ﹤0.01% | 641 |
|
|
2023
Q2 | $51K | Hold |
420
| – | – | ﹤0.01% | 623 |
|
|
2023
Q1 | $65K | Buy |
420
+1
| +0.2% | +$155 | ﹤0.01% | 599 |
|
|
2022
Q4 | $75K | Buy |
419
+127
| +43% | +$22.7K | ﹤0.01% | 587 |
|
|
2022
Q3 | $35K | Hold |
292
| – | – | ﹤0.01% | 621 |
|
|
2022
Q2 | $42K | Hold |
292
| – | – | ﹤0.01% | 603 |
|
|
2022
Q1 | $50K | Buy |
+292
| New | +$50K | ﹤0.01% | 612 |
|
|
2021
Q1 | – | Sell |
-801
| Closed | -$84K | – | 721 |
|
|
2020
Q4 | $84K | Buy |
801
+733
| +1,078% | +$76.9K | ﹤0.01% | 472 |
|
|
2020
Q3 | $5K | Sell |
68
-35
| -34% | -$2.57K | ﹤0.01% | 519 |
|
|
2020
Q2 | $7K | Buy |
+103
| New | +$7K | ﹤0.01% | 492 |
|